Kayleigh Walker is a Medical Writer at Envision Pharma Group with a PhD from the University of Leicester. Her expertise is in translating complex scientific data into clear publications, particularly in diabetes, heart failure, and immunology. Her background is in structure-based drug discovery, leveraging her biochemistry degree from The University of Manchester.
Her doctoral and post-doctoral research focused on using advanced NMR-based methods to inform drug discovery by investigating protein interactions for cancer and inflammatory diseases.
Kayleigh Walker
Medical Writer at Envision Pharma Group
Manchester Area, United Kingdom
Overview
Topics They Care About
Medical Communications
Her current role involves providing medical writing and editorial support for clinical trial publications, podcasts, and posters for pharmaceutical companies.
Structure-based Drug Discovery
Her PhD and postdoctoral research focused on antibody-assisted and NMR-based methods to identify new opportunities for therapeutic targeting of proteins.
Immunology & Oncology
She has co-authored multiple research papers on immune checkpoint proteins like PD-L1 and inflammatory cytokines such as IL-13.
Media Appearances
Kayleigh has no verified media appearances
Work History
10-2022
Medical Writer at Envision Pharma Group
9-2019 - 9-2022
Postdoctoral Research Associate at University of Leicester
11-2018 - 9-2019
Postdoctoral Research Associate at University of Leicester
Education
2014 - 2018
Doctor of Philosophy - PhD from University of Leicester
2010 - 2014
BSc from The University of Manchester
More Information
Social Presence :
Prographics :
Exp : 7
Location : Manchester Area, United Kingdom
Job Level : N/A
Designation : Medical Writer at Envision Pharma Group
